• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞在肌萎缩侧索硬化症治疗中的应用

Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis.

作者信息

Hajivalili Mahsa, Pourgholi Fatemeh, Kafil Hossein Samadi, Jadidi-Niaragh Farhad, Yousefi Mehdi

机构信息

Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Curr Stem Cell Res Ther. 2016;11(1):41-50. doi: 10.2174/1574888x10666150902095031.

DOI:10.2174/1574888x10666150902095031
PMID:26329483
Abstract

Amyotrophic lateral sclerosis (ALS is a neurodegenerative disorder which is characterized by motor neuron (MN dysfunction, progressive paralysis, and death. Although several therapeutic approaches have been used for treatment of ALS, little success has been achieved. Natural vectors such as mesenchymal stem cells (MSCs can be a promising tool for overcoming therapeutic problems. MSCs have multipotential characteristics such as the ability to differentiate into variety of cell types, easy access, immunomodulation, tissue repair, exertion of trophic factors, exosome secretion and efficient homing. In this review, we will discuss the characteristics of MSCs and their possible therapeutic mechanisms in ALS patients.

摘要

肌萎缩侧索硬化症(ALS)是一种神经退行性疾病,其特征为运动神经元(MN)功能障碍、进行性麻痹和死亡。尽管已经采用了多种治疗方法来治疗ALS,但成效甚微。间充质干细胞(MSCs)等天然载体可能是解决治疗难题的一种有前景的工具。MSCs具有多能特性,如能够分化为多种细胞类型、易于获取、免疫调节、组织修复、分泌营养因子、分泌外泌体以及高效归巢。在本综述中,我们将讨论MSCs的特性及其在ALS患者中的可能治疗机制。

相似文献

1
Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis.间充质干细胞在肌萎缩侧索硬化症治疗中的应用
Curr Stem Cell Res Ther. 2016;11(1):41-50. doi: 10.2174/1574888x10666150902095031.
2
The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy - a perspective on cell biological mechanisms.间充质干细胞用于肌萎缩侧索硬化症治疗——细胞生物学机制的视角
Rev Neurosci. 2017 Oct 26;28(7):725-738. doi: 10.1515/revneuro-2017-0018.
3
The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.人骨髓间充质干细胞对肌萎缩侧索硬化症患者外周血单个核细胞的免疫调节作用。
J Neurochem. 2014 Oct;131(2):206-18. doi: 10.1111/jnc.12814. Epub 2014 Jul 31.
4
Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis.间充质干细胞在肌萎缩侧索硬化症中的治疗应用。
Stem Cell Res Ther. 2014;5(2):32. doi: 10.1186/scrt421.
5
Transplantation of mesenchymal stem cells in ALS.肌源性干细胞移植治疗肌萎缩侧索硬化症。
Prog Brain Res. 2012;201:333-59. doi: 10.1016/B978-0-444-59544-7.00016-0.
6
Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.神经基因 1 诱导神经发生增强间充质干细胞在肌萎缩侧索硬化症小鼠模型中的治疗潜力。
Cell Transplant. 2013;22(5):855-70. doi: 10.3727/096368912X637019.
7
Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.间充质干细胞分泌神经营养因子移植治疗肌萎缩侧索硬化症的安全性和临床疗效:1/2 期和 2a 期临床试验结果。
JAMA Neurol. 2016 Mar;73(3):337-44. doi: 10.1001/jamaneurol.2015.4321.
8
Stem cell therapy in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的干细胞治疗。
J Clin Neurosci. 2013 Dec;20(12):1659-63. doi: 10.1016/j.jocn.2013.04.024. Epub 2013 Oct 19.
9
Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.间充质基质细胞的生物标志物作为肌萎缩侧索硬化症患者自体干细胞移植反应的预测指标:一项研究者发起的试验及体内研究
Stem Cells. 2014 Oct;32(10):2724-31. doi: 10.1002/stem.1770.
10
Proteomic analysis of cerebrospinal fluid of amyotrophic lateral sclerosis patients in the presence of autologous bone marrow derived mesenchymal stem cells.肌萎缩侧索硬化症患者脑脊液的蛋白质组学分析在存在自体骨髓间充质干细胞的情况下。
Stem Cell Res Ther. 2024 Sep 15;15(1):301. doi: 10.1186/s13287-024-03820-2.

引用本文的文献

1
Safety and efficacy of bone marrow derived-mesenchymal stem cells transplantation in patients with amyotrophic lateral sclerosis.骨髓间充质干细胞移植治疗肌萎缩侧索硬化症患者的安全性和有效性。
Regen Ther. 2021 Aug 16;18:268-274. doi: 10.1016/j.reth.2021.07.006. eCollection 2021 Dec.
2
The Detrimental and Beneficial Functions of Macrophages After Cochlear Injury.耳蜗损伤后巨噬细胞的有害与有益功能
Front Cell Dev Biol. 2021 Aug 11;9:631904. doi: 10.3389/fcell.2021.631904. eCollection 2021.
3
Articulation recovery in ALS patients after lineage-negative adjuvant cell therapy - preliminary report.
谱系阴性辅助细胞治疗后ALS患者的关节活动恢复——初步报告
Int J Med Sci. 2020 Jul 19;17(13):1927-1935. doi: 10.7150/ijms.47002. eCollection 2020.
4
Role of Mesenchymal Stromal Cells as Therapeutic Agents: Potential Mechanisms of Action and Implications in Their Clinical Use.间充质基质细胞作为治疗剂的作用:潜在作用机制及其临床应用中的意义
J Clin Med. 2020 Feb 6;9(2):445. doi: 10.3390/jcm9020445.
5
Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients.谱系阴性干细胞疗法对肌萎缩侧索硬化症患者发音功能的影响。
Stem Cells Int. 2019 Jun 2;2019:7213854. doi: 10.1155/2019/7213854. eCollection 2019.
6
Evaluation of Peripheral Blood and Cord Blood Platelet Lysates in Isolation and Expansion of Multipotent Mesenchymal Stromal Cells.外周血和脐带血血小板裂解物在多能间充质基质细胞分离和扩增中的评估
Bioengineering (Basel). 2018 Feb 26;5(1):19. doi: 10.3390/bioengineering5010019.
7
Conditioned medium from human gingival mesenchymal stem cells protects motor-neuron-like NSC-34 cells against scratch-injury-induced cell death.人牙龈间充质干细胞条件培养基可保护运动神经元样 NSC-34 细胞免受划痕损伤诱导的细胞死亡。
Int J Immunopathol Pharmacol. 2017 Dec;30(4):383-394. doi: 10.1177/0394632017740976. Epub 2017 Nov 15.
8
Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.神经炎症在肌萎缩侧索硬化症中的作用:细胞机制与治疗意义
Front Immunol. 2017 Aug 21;8:1005. doi: 10.3389/fimmu.2017.01005. eCollection 2017.
9
Roles of exosomes in the normal and diseased eye.外泌体在正常和患病眼睛中的作用。
Prog Retin Eye Res. 2017 Jul;59:158-177. doi: 10.1016/j.preteyeres.2017.04.004. Epub 2017 Apr 29.